Tivity Health (NASDAQ:TVTY) had its price objective boosted by Oppenheimer from $31.00 to $36.00 in a report issued on Thursday, The Fly reports.
Other equities analysts have also issued reports about the stock. BidaskClub lowered shares of Tivity Health from a strong-buy rating to a buy rating in a research report on Wednesday, January 16th. Chardan Capital reiterated a buy rating and set a $31.00 price objective (down from $41.00) on shares of Tivity Health in a research note on Friday, February 1st. Jefferies Financial Group reduced their price objective on shares of Tivity Health to $29.00 and set a buy rating on the stock in a research note on Wednesday, February 20th. SunTrust Banks reduced their price objective on shares of Tivity Health to $28.00 and set a buy rating on the stock in a research note on Wednesday, February 20th. Finally, Craig Hallum assumed coverage on shares of Tivity Health in a research note on Thursday, April 11th. They set a buy rating and a $30.00 price objective on the stock. One investment analyst has rated the stock with a sell rating, eight have given a buy rating and two have issued a strong buy rating to the company’s stock. The stock presently has a consensus rating of Buy and a consensus target price of $33.00.
NASDAQ:TVTY opened at $19.01 on Thursday. Tivity Health has a 52 week low of $16.25 and a 52 week high of $41.46. The stock has a market cap of $905.83 million, a P/E ratio of 8.12, a price-to-earnings-growth ratio of 0.82 and a beta of 1.10. The company has a debt-to-equity ratio of 2.13, a quick ratio of 0.96 and a current ratio of 0.86.
In related news, Director Bradley S. Karro purchased 2,900 shares of Tivity Health stock in a transaction dated Friday, March 22nd. The shares were bought at an average cost of $16.54 per share, for a total transaction of $47,966.00. Following the purchase, the director now owns 24,696 shares in the company, valued at approximately $408,471.84. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Sara Finley purchased 2,000 shares of Tivity Health stock in a transaction dated Wednesday, March 20th. The stock was bought at an average price of $17.25 per share, for a total transaction of $34,500.00. The disclosure for this purchase can be found here. Corporate insiders own 1.64% of the company’s stock.
Several institutional investors and hedge funds have recently bought and sold shares of TVTY. Advisor Group Inc. boosted its stake in shares of Tivity Health by 364.2% in the 4th quarter. Advisor Group Inc. now owns 1,142 shares of the company’s stock valued at $29,000 after purchasing an additional 896 shares in the last quarter. Shell Asset Management Co. acquired a new stake in shares of Tivity Health in the 1st quarter valued at approximately $33,000. Pearl River Capital LLC acquired a new stake in shares of Tivity Health in the 1st quarter valued at approximately $36,000. Enlightenment Research LLC acquired a new stake in Tivity Health during the 4th quarter worth approximately $37,000. Finally, Asset Dedication LLC acquired a new stake in Tivity Health during the 1st quarter worth approximately $46,000. Institutional investors own 94.73% of the company’s stock.
Tivity Health Company Profile
Tivity Health, Inc provides fitness and health improvement programs in the United States. The company offers SilverSneakers senior fitness program to the members of Medicare advantage, Medicare supplement; and Prime fitness, a fitness facility access program through commercial health plans and employers.
See Also: Exchange-Traded Funds (ETFs)
Receive News & Ratings for Tivity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivity Health and related companies with MarketBeat.com's FREE daily email newsletter.